Cargando…

The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients

BACKGROUND: The aim of this study was to evaluate the effect on the number of performed biopsies and costs associated with implementing positron emission tomography (PET) and computed tomography (PET/CT) with 16α-[(18)F]fluoro-17β-oestradiol (FES) or 2-[(18)F]fluoro-2-deoxy-D-glucose (FDG) as an upf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koleva-Kolarova, R G, Greuter, M J W, van Kruchten, M, Vermeulen, K M, Feenstra, T, Buskens, E, Glaudemans, A W J M, de Vries, E F J, de Vries, E G E, Hospers, G A P, de Bock, G H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430721/ https://www.ncbi.nlm.nih.gov/pubmed/25880006 http://dx.doi.org/10.1038/bjc.2015.138

Ejemplares similares

Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer: a cost-effectiveness study
por: Koleva-Kolarova, Rositsa G., et al.
Publicado: (2018)

Enhanced pulmonary uptake on (18)F-FES-PET/CT scans after irradiation of the thoracic area: related to fibrosis?
por: Venema, C. M., et al.
Publicado: (2019)

Analyzing the Estrogen Receptor Status of Liver Metastases with [(18)F]-FES-PET in Patients with Breast Cancer
por: Boers, Jorianne, et al.
Publicado: (2021)

Image Quality and Interpretation of [(18)F]-FES-PET: Is There any Effect of Food Intake?
por: Boers, Jorianne, et al.
Publicado: (2020)

Application of PET Tracers in Molecular Imaging for Breast Cancer
por: Boers, Jorianne, et al.
Publicado: (2020)

Visual and quantitative evaluation of [(18)F]FES and [(18)F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study
por: Mammatas, Lemonitsa H., et al.
Publicado: (2020)

Positron emission tomography of tumour [(18)F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy
por: van Kruchten, Michel, et al.
Publicado: (2015)

Molecular imaging as biomarker for treatment response and outcome in breast cancer
por: van Geel, Jasper J. L., et al.
Publicado: (2023)

Monitoring the Crosstalk Between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 with PET
por: Antunes, I. F., et al.
Publicado: (2020)

A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using (18)F-FES PET/CT imaging
por: Jager, Agnes, et al.
Publicado: (2020)

Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness
por: de Bock, G H, et al.
Publicado: (2013)

Early health technology assessment of magnetic resonance-guided high intensity focused ultrasound ablation for the treatment of early-stage breast cancer
por: Knuttel, Floortje M., et al.
Publicado: (2017)

The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.
por: Hospers, G. A., et al.
Publicado: (1990)

The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects
por: Hospers, G A P, et al.
Publicado: (1999)

Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative (18)F-FDG PET/CT analysis
por: de Heer, Ellen C., et al.
Publicado: (2018)

Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy
por: van de Donk, Pim P., et al.
Publicado: (2021)

The Use of (18)F-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and Infectious Diseases
por: Glaudemans, Andor W. J. M., et al.
Publicado: (2013)

Development of a dynamic myocardial perfusion phantom model for tracer kinetic measurements
por: Kamphuis, Marije E., et al.
Publicado: (2022)

Role of FDG-PET/CT in children with fever of unknown origin
por: Pijl, Jordy P., et al.
Publicado: (2020)

FDG-PET/CT in infections: the imaging method of choice?
por: Glaudemans, Andor W. J. M., et al.
Publicado: (2010)

Variability of [(18)F]FDG-PET/LDCT reporting in vascular graft and endograft infection
por: Liesker, David J., et al.
Publicado: (2023)

Beyond FDG: novel PET tracers for cancer imaging
por: Hicks, Rodney J
Publicado: (2003)

Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer (89)Zr-imgatuzumab
por: Pool, Martin, et al.
Publicado: (2016)

The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
por: Meijer, C., et al.
Publicado: (1990)

Influence of O and C co-implantation on the lattice site of Er in GaN
por: De Vries, Bart, et al.
Publicado: (2004)

The Vienna FES Interview Protocol – A mixed-methods protocol to elucidate the opinions of various individuals responsible for the provision of FES exercise
por: Taylor, Matthew J., et al.
Publicado: (2017)

Experimental evidence of tetrahedral interstitial and bond-centered Er in Ge
por: Decoster, S, et al.
Publicado: (2008)

Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis
por: van der Geest, K. S. M., et al.
Publicado: (2020)

Home FES: An Exploratory Review
por: Taylor, Matthew J., et al.
Publicado: (2019)

A randomized crossover study of functional electrical stimulation during walking in spastic cerebral palsy: the FES on participation (FESPa) trial
por: Moll, Irene, et al.
Publicado: (2022)

Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield
por: Montes de Jesus, F. M., et al.
Publicado: (2019)

Effect of fluence on the lattice site of implanted Er and implantation induced strain in GaN
por: Wahl, U, et al.
Publicado: (2009)

Objective allergy markers and risk of cancer mortality and hospitalization in a large population-based cohort
por: Taghizadeh, Niloofar, et al.
Publicado: (2014)

Diagnostic value of [18F]FDG-PET/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis
por: van der Geest, K. S. M., et al.
Publicado: (2021)

Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation
por: Toner, Yohana C., et al.
Publicado: (2022)

[(18)F]FES uptake in the pituitary gland and white matter of the brain
por: Iqbal, R., et al.
Publicado: (2021)

Tracer and Non-Tracer Potassium Fluxes in Frog Sartorius Muscle and the Kinetics of Net Potassium Movement
por: Sjodin, R. A., et al.
Publicado: (1964)

Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis
por: de Graeff, P, et al.
Publicado: (2009)

Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer
por: Falahi, Fahimeh, et al.
Publicado: (2014)

(18)F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
por: Nienhuis, Pieter H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_neldbcmer5941g4s59te259fqu